How Oligonucleotides Work Their Magic
By Hilary Brooks
August 20, 2025
Pharma is investing big in oligonucleotides, but what is it that makes this class of drugs so special? We find out.
10 min read
False
By Hilary Brooks
August 20, 2025
Pharma is investing big in oligonucleotides, but what is it that makes this class of drugs so special? We find out.
10 min read
By Stephanie Vine
July 28, 2025
Established medicine to swap to new formulation.
2 min read
June 25, 2025
Why spray-drying could reduce supply chain costs, address infrastructure challenges, and pave the way for intranasal mRNA vaccine delivery.
5 min read
By Stephanie Vine
June 24, 2025
Researchers explore how ocular gene delivery strategies for diabetic retinopathy could be improved using nanotechnology.
3 min read
June 20, 2025
A new approach to tackling the blood-brain barrier is attracting attention from big pharma.
5 min read
By Rob Coker
June 4, 2025
Recent developments in the treatment of psoriasis has brought new hope to sufferers, and a surge in market standings.
4 min read
By Stephanie Vine
May 30, 2025
From different modalities to overcoming aggregation; we find out what advances are affecting the development of ADCs.
3 min read
By Stephanie Vine
May 7, 2025
Researchers say they have found a method that will allow some large molecules to be administered orally
2 min read
By Stephanie Vine
May 6, 2025
What’s going on in nasal drug delivery? We spoke with Kim Earnst, VP of product development and laboratory service at Renaissance Lakewood to get a glimpse of the latest trends and challenges in the area.
3 min read
By Stephanie Vine
May 1, 2025
Scientists explain how inhalable gene therapies are being developed to treat cystic fibrosis.
5 min read
False
False
False